InveStigAting Bladder fiELd-cycLing imAging
NCT05846165 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2024-10-08
Summary
The goal of this pilot study is explore the parameters that can be obtained in bladder tumours by Field-Cycling Imaging (FCI) in patients with both muscle-invasive and non-muscle invasive tumours. The main question it aims to answer is if FCI can give more diagnostic information than conventional tests.
Participants will have one FCI scan and the results will be correlated with the results of CT urogram or CT scan.
Conditions
Interventions
- DEVICE
-
Field-Cycling Imaging (FCI)
FCI scan
Sponsors & Collaborators
-
NHS Grampian
collaborator OTHER_GOV -
University of Aberdeen
lead OTHER
Principal Investigators
-
Anne Kiltie, Prof · University of Aberdeen
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-31
- Primary Completion
- 2024-03-31
- Completion
- 2024-03-31
More Related Trials
-
Near Infrared Fluorescence Imaging for Bladder Cancer Detection
NCT03058705 ·Status: COMPLETED ·Phase: NA
-
Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer
NCT05687721 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
NCT04018053 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer
NCT02494635 ·Status: TERMINATED
-
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
NCT02496208 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer
NCT05445648 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer
NCT07251946 ·Status: COMPLETED
-
Mapping 3D Bladder
NCT05260788 ·Status: WITHDRAWN
-
Cabozantinib for Advanced Urothelial Cancer
NCT01688999 ·Status: COMPLETED ·Phase: PHASE2
-
Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology
NCT00801762 ·Status: COMPLETED
-
Detection of Disease in the Upper Tract
NCT05349812 ·Status: WITHDRAWN
-
Study of Weekly Radiotherapy for Bladder Cancer
NCT01810757 ·Status: COMPLETED ·Phase: NA
-
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
NCT04701918 ·Status: COMPLETED ·Phase: PHASE2
-
Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer
NCT05324033 ·Status: COMPLETED
-
Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study
NCT07111364 ·Status: RECRUITING
-
Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm
NCT05779631 ·Status: RECRUITING ·Phase: NA
-
Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer
NCT04726735 ·Status: COMPLETED
-
Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy
NCT03106610 ·Status: TERMINATED ·Phase: PHASE1
-
NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment
NCT06537154 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC
NCT04897763 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Longitudinal Bladder Cancer Study for Tumour Recurrence
NCT05080998 ·Status: RECRUITING
-
Image-Guided Tumorboost of Bladder Cancer
NCT00963404 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer
NCT04779489 ·Status: TERMINATED ·Phase: NA
-
Markers of Response to Intravesical Bladder Cancer Therapy
NCT01007058 ·Status: COMPLETED
-
Narrow-band Imaging Diagnostic Classification System for Bladder Tumors
NCT05611762 ·Status: UNKNOWN